Search

Your search keyword '"Smeltzer M"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Smeltzer M" Remove constraint Author: "Smeltzer M"
270 results on '"Smeltzer M"'

Search Results

9. EP01.06-007 The Impact of Modified Screening Eligibility Criteria on Race and Sex Disparities in Lung Cancer Screening

10. EP02.03-022 Evolution of Lung Cancer Resection Quality: A Prospective Staggered Implementation Quality Improvement Study

13. MA17.05 Intrapulmonary Lymph Node (LN) Retrieval With a Novel Gross Dissection Method: A Prospective, Population-Based Cohort Study

14. P53.06 A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers

15. OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

17. MA10.02 Lung Cancer Detected By Screening, Incidental Lung Nodule Program and Neither: A Prospective Observational Study

18. P62.05 Identifying Risk-Factors for Lung Cancer Diagnosis After Detection of Incidental Lung Nodules

19. The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

21. MA09.08 Improving Overall Survival in Non-Small Cell Lung Cancer by Reducing R-Uncertain Resections With a Lymph Node Specimen Collection Kit

23. MA03.05 Hierarchy of Adverse-Prognosis Quality Markers after Curative-Intent Resection of Non-Small Cell Lung Cancer (NSCLC)

24. MA09.10 Location of Lymph Nodes Missed after Invasive Mediastinal Staging in a Well-Staged Non-Small Cell Lung Cancer Cohort

26. OFP01.04 Improving Quality of Pathology Reports for Resected Non-Small Cell Lung Cancer (NSCLC) in the Mid-South US

27. MO01.11 The Relative Survival Impact of Thorough Staging and Appropriate Treatment in Non-Small-Cell Lung Cancer (NSCLC)

31. O.04 Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

32. OA01.09 Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

36. MA21.03 The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer

38. Differential RNA regulation by staphylococcal enterotoxins A and B in murine macrophages

39. Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus

40. P2.16-32 Survival Implications and Factors Associated with the Anatomic Level of Incomplete Non-Small-Cell Lung Cancer (NSCLC) Resection

41. P1.17-11 Pattern and Survival Impact of Neoadjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) in a Prospective Lung Resection Cohort

42. P1.16-46 A Population-Based Validation Study of the Proposed ‘R-Factor’ Classification in a Lung Cancer-Endemic Region of the US

43. P2.16-38 Characteristics of Preoperative N Staging in Patients with Optimal Pathologic N Staging of Non Small Cell Lung Cancer(NSCLC)

44. P1.11-11 Comparing Lung Cancer Diagnosed by Low Dose CT (LDCT), Incidental Lung Nodule Program (ILNP), and Non-Program-Based Detection

45. MA25.05 Characteristics and Survival of Resected Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Mid-South Quality of Surgical Resection Cohort

47. OA 15.08 Thoroughness of Staging and the Outcomes of Surgical Resection Outcomes in Potentially Curable Non-Small Cell Lung Cancer (NSCLC)

48. P2.16-019 Improving Survival with a Lymph Node (LN) Collection Kit for Non-Small Cell Lung Cancer (NSCLC) Resections

49. MA 04.01 Prospective Comparative Evaluation of Patient and Caregiver Perspectives on a Multidisciplinary Model of Lung Cancer Care

50. P1.13-011 Prospective Cohort Study of Patterns of Staging and Treatment Selection with or Without Multidisciplinary (MD) Care

Catalog

Books, media, physical & digital resources